UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Government urged to depart from 'disease-oriented' psychiatric R&D investment
Although the Korean government has expanded investment into the research an...
by Nam Doo-hyun
|
2017-03-21 16:19
라인
Korean drug makers struggle in Central Asia
Kazakhstan and Uzbekistan rely heavily on imported medicines, but Korean dr...
by Nam Doo-hyun
|
2017-03-17 09:13
라인
China's economic retaliation spreads to healthcare sector
Korea’s export of medical supplies to China, including medicines, fell shar...
by Nam Doo-hyun
|
2017-03-16 09:39
라인
Why some pharms' operating profits plunged last year?
Among Korea’s major pharmaceutical companies, three – Hanmi Pharm, Do...
by Nam Doo-hyun
|
2017-03-08 18:18
라인
Expert laments three 'nos' in drug industry
Practically every pharmaceutical company CEO outlines his or her aspiration...
by Nam Doo-hyun
|
2017-03-03 11:32
라인
InBody's export increase raises hopes for 2017 growth
InBody, a company analyzing body composition that registered record-high sa...
by Nam Doo-hyun
|
2017-03-02 16:20
라인
Can Hongneung area be reborn as 'bio cluster'?
A biomedical industrial complex will open in Hongneung, northern Seoul, in ...
by Nam Doo-hyun
|
2017-02-27 17:08
라인
'Troublemaker Doctor' out of the Hospital and into the Hot Bio-Industry
Ever since the various applications of stem cells came to light in 1998, pu...
by Nam Doo-hyun
|
2017-02-16 08:30
라인
VR Use on the Rise in Medical Fields
It is predicted that VR (Virtual Reality) will be commonly used in medical ...
by Nam Doo-hyun
|
2017-02-15 18:07
라인
It’s a War, Not a Battle
GemVax & KAEL is one of Korea’s top bio businesses in developing new drugs....
by Nam Doo-hyun
|
2017-02-15 08:00
라인
Samsung BioLogics Refutes KOSPI Listing Suspicions
Samsung BioLogics denies allegations of lobbying the Blue House and receivi...
by Nam Doo-hyun
|
2017-02-11 08:49
라인
Korea’s Gene Analysis Technology Goes Global with Spearhead Macrogen
With the rise of gene medicine, gene analysis technology and the latest inf...
by Nam Doo-hyun
|
2017-02-07 12:27
라인
“Korean Medical Devices, Good Brand Images but More Expensive than Chinese Ones”
Foreign buyers evaluated they like Korean medical device brands, but Korean...
by Nam Doo-hyun
|
2017-01-31 14:31
라인
Research Centered Hospitals of Korea: “Numbers Do Not Matter”
What can Korea do to develop new, world-class drugs?Perhaps the answer is b...
by Nam Doo-hyun
|
2017-01-31 12:26
라인
Lackluster Genome Analysis Industry in Korea; Calls for Localization
Although the genome analysis industry is increasing dramatically, Korean eq...
by Nam Doo-hyun
|
2017-01-31 08:22
라인
Japan Trying to Benchmark Korean Bio Industry Complex
The Korea Institute for Industrial Economics & Trade (KIET) analyzed that J...
by Nam Doo-hyun
|
2017-01-26 08:37
라인
“Building a Bio Complex Where More than 50,000 Medical Personnel Can Work”
Paju city announced it would make the world’s largest bio medical industria...
by Nam Doo-hyun
|
2017-01-24 10:23
라인
7 Things Hospitals for Overseas Expansion Should Keep in Mind
The government prepared for a supportive measure for medical institutions t...
by Nam Doo-hyun
|
2017-01-20 10:56
라인
Bio and Pharmaceutical Stocks Smiling in the First Week of 2017
Some bio and pharmaceutical companies whose stock prices drop range were la...
by Nam Doo-hyun
|
2017-01-17 09:09
라인
Last Year, Export and Import of Pharmaceutical Products Exceeded $2billion and $5billion for the First Time
Last year, the amount of money for export and import of pharmaceutical prod...
by Nam Doo-hyun
|
2017-01-06 15:15
-
이전
11
12
13
14
15
16
17
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top